A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma.

MLA

Mok, T. S., et al. “A Phase II Study of Gemcitabine plus Oral Etoposide in the Treatment of Patients with Advanced Nonsmall Cell Lung Carcinoma.” Cancer, vol. 89, no. 3, Aug. 2000, pp. 543–50. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10931453&authtype=sso&custid=ns315887.

APA

Mok, T. S., Zee, B., Chan, A. T., Yeo, W., Yang, W. T., Yim, A., Leung, S. F., Nguyen, B., Leung, T. W., & Johnson, P. (2000). A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma. Cancer, 89(3), 543–550.

Chicago

Mok, T S, B Zee, A T Chan, W Yeo, W T Yang, A Yim, S F Leung, B Nguyen, T W Leung, and P Johnson. 2000. “A Phase II Study of Gemcitabine plus Oral Etoposide in the Treatment of Patients with Advanced Nonsmall Cell Lung Carcinoma.” Cancer 89 (3): 543–50. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10931453&authtype=sso&custid=ns315887.